Related Experiment Video
Updated: May 20, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Evolving dynamics in clinical trials for oral cancer: Trends, treatment modalities, and future directions
Yihao Pei1, Ziqi Yang1, Yiming Mao2
1Medical College of Jinzhou Medical University, Jinzhou 121000, China.
Clinical Trial Trends:
Analysis of clinical trials from 2004 to 2024 reveals a steady increase in research, with a peak in 2021, and a notable shift towards early-phase trials focusing on safety and preliminary efficacy evaluations.
Dominant Intervention Types:
Drug-based interventions dominate clinical trials, with Cisplatin, Ixazomib, and Dexamethasone being the most frequently used drugs. Recent years show a growing trend towards immunotherapy, with Pembrolizumab emerging as a key agent.
Future Directions:
Future research should focus on large-scale, long-term clinical trials to validate the effectiveness of emerging therapies, particularly immunotherapies, and explore combination therapies that integrate immunotherapy with other modalities.
Insights
Clinical trial research increased steadily until 2021, with a focus on early-phase safety and efficacy. Drug interventions, especially immunotherapy, are prominent, necessitating further large-scale trials for validation.
Area of Science:
- Oncology
- Clinical Pharmacology
Background:
- Analysis of clinical trials from 2004-2024 shows a consistent rise in research activity.
- A significant trend towards early-phase trials evaluating safety and preliminary efficacy has been observed.
Purpose of the Study:
- To analyze trends in clinical trial research over two decades.
- To identify dominant intervention types and emerging therapeutic strategies.
Main Methods:
- Retrospective analysis of clinical trial data from 2004 to 2024.
- Identification and categorization of intervention types, including specific drugs and therapeutic modalities.
Main Results:
- Clinical trial research peaked in 2021, with a notable increase in early-phase studies.
- Drug-based interventions, including Cisplatin, Ixazomib, and Dexamethasone, are most common.
- A growing trend towards immunotherapy, with Pembrolizumab as a key agent, is evident in recent years.
Conclusions:
- Future research should prioritize large-scale, long-term clinical trials.
- Validation of emerging therapies, particularly immunotherapies, is crucial.
- Exploration of combination therapies integrating immunotherapy with other treatment modalities is recommended.
More Related Videos
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...